Advaxis Inc (NASDAQ:ADXS) - Overview

Stock Report

Advaxis Inc ADXS

Last Price
$8.02

Day Change
-0.29|-3.49%

As of 01/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close8.31
Day Range7.95 - 8.39
Mkt Cap328.70Mil
52-Wk Range5.21 - 16.30
Yield %-
ISINUS0076242082
Volume852,548
P/E-4.22
P/S1,080.13
P/CF-6.74

Share Price

Financials
201320142015
More ...
Income Statement
Revenue0.001.000.00
Operating Income-14.69-19.54-48.67
Net Income-19.99-16.53-47.03
Basic EPS-4.10-0.97-1.68
Avg. Diluted Shares Outstanding51728
Balance Sheet
Current Assets20.8120.49115.01
Non Current Assets2.782.884.59
Total Assets23.5923.38119.61
Current Liabilities4.942.723.92
Total Liabilities5.582.754.01
Total Equity18.0020.63115.60
Cash Flow
Operating Cash Flow-8.71-17.02-24.14
Capital Expenditure-0.30-0.44-1.79
Free Cash Flow-9.01-17.46-25.93

In millions, except "Basic EPS". Currency is USD.

Company Profile

Advaxis Inc is a clinical development stage biotechnology company. The Company is engaged in discovery, development and commercialization of Lm-LLO immunotherapies for cancer and infectious diseases.

Sector

Healthcare

Industry

Biotechnology

Fiscal Year Ends

October

Employees

48
Key Stats
More ...
Price/Earning TTM-4.37
Price/Book3.96
Price/Sales TTM1,122.97
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-Infinity
Net Margin % TTM-Infinity
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.